Aktiesnakken — Oktober 2010
-
men stort set ALLE US patenter jeg finder, har fået en non final rejection til at starte med
-
var også lige denne her Doctor http://clinicaltrialsfeeds.org/clinical-trials/show/NCT01227122
-
Det må da siges at være ret seriøst
-
har du set alle de andre indikationer der er kommet fornyligt, hvor NGAL bliver sat i relation
-
lungepatienter, hjernesvulster, kræft, ved måling i galde, og brystkræft
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind